Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
2001
46K+
LTM Revenue $313B
LTM EBITDA $4.5B
$62.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cencora has a last 12-month revenue (LTM) of $313B and a last 12-month EBITDA of $4.5B.
In the most recent fiscal year, Cencora achieved revenue of $294B and an EBITDA of $3.4B.
Cencora expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Cencora valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $313B | XXX | $294B | XXX | XXX | XXX |
Gross Profit | $10.2B | XXX | $9.9B | XXX | XXX | XXX |
Gross Margin | 3% | XXX | 3% | XXX | XXX | XXX |
EBITDA | $4.5B | XXX | $3.4B | XXX | XXX | XXX |
EBITDA Margin | 1% | XXX | 1% | XXX | XXX | XXX |
EBIT | $4.0B | XXX | $3.2B | XXX | XXX | XXX |
EBIT Margin | 1% | XXX | 1% | XXX | XXX | XXX |
Net Profit | $3.0B | XXX | $1.5B | XXX | XXX | XXX |
Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $1.3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cencora's stock price is $291.
Cencora has current market cap of $56.4B, and EV of $62.3B.
See Cencora trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$62.3B | $56.4B | XXX | XXX | XXX | XXX | $15.10 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cencora has market cap of $56.4B and EV of $62.3B.
Cencora's trades at 0.2x EV/Revenue multiple, and 16.9x EV/EBITDA.
Equity research analysts estimate Cencora's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cencora has a P/E ratio of 19.0x.
See valuation multiples for Cencora and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $56.4B | XXX | $56.4B | XXX | XXX | XXX |
EV (current) | $62.3B | XXX | $62.3B | XXX | XXX | XXX |
EV/Revenue | 0.2x | XXX | 0.2x | XXX | XXX | XXX |
EV/EBITDA | 14.0x | XXX | 16.9x | XXX | XXX | XXX |
EV/EBIT | 15.6x | XXX | 18.3x | XXX | XXX | XXX |
EV/Gross Profit | 6.1x | XXX | n/a | XXX | XXX | XXX |
P/E | 19.0x | XXX | 29.7x | XXX | XXX | XXX |
EV/FCF | 22.3x | XXX | 21.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCencora's last 12 month revenue growth is 8%
Cencora's revenue per employee in the last FY averaged $6.4M, while opex per employee averaged $0.1M for the same period.
Cencora's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cencora's rule of X is 21% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cencora and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 8% | XXX | 8% | XXX | XXX | XXX |
EBITDA Margin | 1% | XXX | 1% | XXX | XXX | XXX |
EBITDA Growth | 10% | XXX | 18% | XXX | XXX | XXX |
Rule of 40 | 9% | XXX | 9% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 21% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $6.4M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Ghitha Holding | XXX | XXX | XXX | XXX | XXX | XXX |
Acomo | XXX | XXX | XXX | XXX | XXX | XXX |
Sligro Food Group | XXX | XXX | XXX | XXX | XXX | XXX |
Metcash | XXX | XXX | XXX | XXX | XXX | XXX |
Reece | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cencora acquired XXX companies to date.
Last acquisition by Cencora was XXXXXXXX, XXXXX XXXXX XXXXXX . Cencora acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Cencora founded? | Cencora was founded in 2001. |
Where is Cencora headquartered? | Cencora is headquartered in United States of America. |
How many employees does Cencora have? | As of today, Cencora has 46K+ employees. |
Who is the CEO of Cencora? | Cencora's CEO is Mr. Robert P. Mauch. |
Is Cencora publicy listed? | Yes, Cencora is a public company listed on NYS. |
What is the stock symbol of Cencora? | Cencora trades under COR ticker. |
When did Cencora go public? | Cencora went public in 1995. |
Who are competitors of Cencora? | Similar companies to Cencora include e.g. Ghitha Holding, Acomo, Sligro Food Group, Metcash. |
What is the current market cap of Cencora? | Cencora's current market cap is $56.4B |
What is the current revenue of Cencora? | Cencora's last 12 months revenue is $313B. |
What is the current revenue growth of Cencora? | Cencora revenue growth (NTM/LTM) is 8%. |
What is the current EV/Revenue multiple of Cencora? | Current revenue multiple of Cencora is 0.2x. |
Is Cencora profitable? | Yes, Cencora is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Cencora? | Cencora's last 12 months EBITDA is $4.5B. |
What is Cencora's EBITDA margin? | Cencora's last 12 months EBITDA margin is 1%. |
What is the current EV/EBITDA multiple of Cencora? | Current EBITDA multiple of Cencora is 14.0x. |
What is the current FCF of Cencora? | Cencora's last 12 months FCF is $2.8B. |
What is Cencora's FCF margin? | Cencora's last 12 months FCF margin is 1%. |
What is the current EV/FCF multiple of Cencora? | Current FCF multiple of Cencora is 22.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.